Sponsor pipeline

Chinese SLE Treatment And Research Group clinical trial pipeline

Get alerts when Chinese SLE Treatment And Research Group's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 1
1
Phase 2/3
2
Phase 3
1
Phase 4
7
Not charted: 2 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT05965284 Efficacy and Safety for Telitacicept in the Remission Maintenance Treatment of… ANCA-associated Vasculitis Recruiting 2023-07-28
NCT05962840 Efficacy and Safety for Rituximab Combined With Telitacicept in the Treatment of… ANCA Associated Vasculitis Recruiting 2023-07-27
NCT07643038 Treatment Strategy for Patients With RA-ILD Rheumatoid Arthritis Associated Interstitial Lung Disease Not Yet Recruiting 2026-09-03
NCT07381465 Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus Erythematosus Lupus Erythematosus, Systemic Active, Not Recruiting 2026-07-15
NCT07451665 Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active… Takayasu Arteritis (TAK) Not Yet Recruiting 2026-03-05
NCT07013838 The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis Takayasu Arteritis (TAK) Not Yet Recruiting 2025-06-10
NCT07008196 Telitacicept for the Treatment of Refractory RA Rheumatoid Arthritis (RA) Not Yet Recruiting 2025-06-06
Phase 3
NCT04582136 Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus Systemic Lupus Erythematosus Active, Not Recruiting 2025-09-26
Phase 2/3
NCT07657793 Sirolimus in Patients With Systemic Lupus Erythematosus-Associated Immune Thrombocytopenia Systemic Lupus Erythematosus Recruiting 2026-06-18
NCT07814664 Ivarmacitinib Versus Glucocorticoids in Mild-to-Moderate Systemic Lupus Erythematosus Systemic Lupus Erthematosus Not Yet Recruiting 2026-09-11
Phase 1
NCT06881290 Vunakizumab for the Treatment of Mild to Moderate Systemic Lupus Erythematosus Lupus Erythematosus, Systemic Recruiting 2025-07-10
Not specified
NCT06887517 Chinese Rheumatism Biobank(CRB) Lupus Erythematosus, Systemic Recruiting 2025-04-09
NCT06167174 Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics… Lupus Nephritis Recruiting 2023-12-12

Disease areas by active trials

Lupus (SLE) (7) · Rheumatoid Arthritis (2)

Get alerts when Chinese SLE Treatment And Research Group's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free